您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[国盛证券]:【周专题&周观点】【总第 407 期】:20张图表详解2025Q2公募基金医药持仓背后的变化 - 发现报告

【周专题&周观点】【总第 407 期】:20张图表详解2025Q2公募基金医药持仓背后的变化

2025-07-27张金洋、胡偌碧、徐雨涵国盛证券周***
AI智能总结
查看更多
【周专题&周观点】【总第 407 期】:20张图表详解2025Q2公募基金医药持仓背后的变化

请仔细阅读本报告末页声明增持(维持)行业走势作者分析师张金洋执业证书编号:S0680519010001邮箱:zhangjinyang@gszq.com分析师胡偌碧执业证书编号:S0680519010003邮箱:huruobi@gszq.com分析师徐雨涵执业证书编号:S0680524040006邮箱:xuyuhan@gszq.com相关研究1、《医药生物:“小核酸”相关布局公司有哪些?他们干了啥?周创新药大牛市】分支思路(三)中小市值科技革命周周题&周观点】周总第406期】》2025-07-192、《医药生物:A/H器械公司25H1涨幅榜前20缘何强势?周周题&周观点】周总第405期】》2025-07-123、《医药生物:周周题&周观点】【周总第404期】从海外映射寻找下半年创新药新赛道》2025-07-06-10%0%10%20%30%40%2024-072024-112025-032025-07医药生物沪深300 P.2内容目录一、医药核心观点..................................................................................................................................4二、20张图表详解2025Q2公募基金医药持仓背后的变化..........................................................................62.1仓位:非医药主动基金从低配转至超配,有持续增配空间................................................................72.2配置:创新药产业链获得显著增配..............................................................................................102.3梳理:医药基金规模、股票投资市值与占基金资产总值比例的历史变化..........................................14三、细分领域投资策略及思考................................................................................................................183.1广义药品..................................................................................................................................183.1.1创新药............................................................................................................................183.1.2仿制药............................................................................................................................193.1.3中药...............................................................................................................................213.2医疗器械板块周度复盘.............................................................................................................223.3配套领域..................................................................................................................................253.3.1CXO................................................................................................................................253.3.3药店...............................................................................................................................263.3.4医药商业........................................................................................................................273.3.4医疗服务........................................................................................................................273.3.5生命科学产业链上游周度复盘...........................................................................................27四、医药行情回顾与热点追踪................................................................................................................304.1医药行业行情回顾.....................................................................................................................304.2医药行业热度追踪.....................................................................................................................334.3医药板块个股行情回顾..............................................................................................................35风险提示.............................................................................................................................................36图表目录图表1:2025Q2公募基金重仓持有A股医药股数量、医药股市值与持股市值比...........................................6图表2:2006-2025Q2公募基金重仓持股的医药仓位变化趋势图................................................................7图表3:2023Q3-2025Q2公募基金重仓持股的医药仓位及超配比例数据表..................................................8图表4:2025Q2医药基金重仓持股的医药仓位分布..................................................................................8图表5:2025Q2非医药主动型基金重仓持股的医药仓位分布.....................................................................8图表6:2025Q2医药基金重仓持股的港股医药仓位分布...........................................................................9图表7:2025Q2非医药主动型基金重仓持股的港股医药仓位分布..............................................................9图表8:2025Q2医药基金重仓持股的医药仓位环比变化...........................................................................9图表9:2025Q2非医药主动型基金重仓持股的医药仓位环比变化..............................................................9图表10:2025Q2医药基金重仓持股的港股医药仓位环比变化.................................................................10图表11:2025Q2非医药主动型基金重仓持股的港股医药仓位环比变化....................................................10图表12:2025Q2公募基金重仓持股的医药持有基金数环比变化..............................................................11图表13:2025Q2公募基金重仓持股的医药持股市值及持股市值比环比变化..............................................12图表14:2025Q2公募基金重仓持股的港股医药生物公司持有基金数环比变化..........................................13图表15:2025Q2公募基金重仓持股的港股医药生物公司持股市值及持股市值比环比变化..........................14图表16:2012Q1至今公募医药主基金规模合计与对应报告期TOP30基金规模均值(右轴)的历史变化..15图表17:2012Q1至今公募医药主基金的股票投资市值与占基金资产总值比例的历史变化.......................15图表18:主动医药基金及非主动医药基金规模.......................................................................................16图表19:医药基金资产总值变化动因分析(亿元)................................................................................16图表20:2024Q4-2025Q2主动医药基金医药持仓子行业比例变化....................................................